Janos Paloczi

Citado por

	Total	Desde 2020
Citas	2013	1459
Índice h	24	20
Índice i10	37	34

300

150

225

201320142015201620172018201920202021202220232024202514 38 43 58 87 124 170 244 298 293 280 295 49

Acceso público

Ver todo

41 artículos

3 artículos

disponibles

no disponibles

Basado en requisitos de financiación

Coautores

Pal PacherNational Institutes of Health, BethesdaDirección de correo verificada de mail.nih.gov
Péter FerdinandySemmelweis University, Budapest; Pharmahungary Group, Szeged, HungaryDirección de correo verificada de pharmahungary.com
Zoltan VargaSemmelweis University, HCEMMDirección de correo verificada de med.semmelweis-univ.hu
Görbe AnikóSemmelweis University, University of SzegedDirección de correo verificada de med.u-szeged.hu
Tamás CsontUniversity of SzegedDirección de correo verificada de med.u-szeged.hu
george haskoColumbia UniversityDirección de correo verificada de cumc.columbia.edu
Péter BencsikUniversity of Szeged & Pharmahungary GroupDirección de correo verificada de med.u-szeged.hu
Csaba MatyasMedical School, University of PécsDirección de correo verificada de pte.hu
Bin GaoChief, Laboratory of Liver Diseases, NIAAA, NIHDirección de correo verificada de mail.nih.gov
C CsonkaUniversity of szegedDirección de correo verificada de med.u-szeged.hu
Resat CinarNational Institute on Alcohol Abuse and Alcoholism / National Institutes of HealthDirección de correo verificada de nih.gov
Katalin Erdelyipost doctoral fellowDirección de correo verificada de mail.nih.gov
Partha Mukhopadhyay, MS, Ph.D.National Institutes of HealthDirección de correo verificada de mail.nih.gov
George KunosScientific Director, NIAAA/NIHDirección de correo verificada de nih.gov
Renáta GáspárPostdoctor, SZTE Albert Szent-Györgyi Medical School, Department of BiochemistryDirección de correo verificada de med.u-szeged.hu
Márta SárközyUniversity of Szeged, Albert Szent-Györgyi Medical School, Department of PathophysiologyDirección de correo verificada de med.u-szeged.hu
Gabriella Kocsis-FodorDrDirección de correo verificada de novartis.com
Gergő SzűcsDepartment of Biochemistry, Albert Szent-Györgyi Medical School, University of SzegedDirección de correo verificada de med.u-szeged.hu
Ágnes ZvaraSenior scientist, Biological Research Center, Szeged, HungaryDirección de correo verificada de brc.hu
Puskas Laszlo GHAS, Biological Research Center, Avidin Ltd.Dirección de correo verificada de brc.hu

Seguir

Janos Paloczi

LSU Health Science Center

Dirección de correo verificada de lsuhsc.edu

cardiovascular research molecular cardiology endocannabinoid signaling eicosanoid signaling


Título Ordenar por citas Ordenar por año Ordenar por título	Citado por Citado por	Año
MicroRNA-25-dependent up-regulation of NADPH oxidase 4 (NOX4) mediates hypercholesterolemia-induced oxidative/nitrative stress and subsequent dysfunction in the heart ZV Varga, K Kupai, G Szűcs, R Gáspár, J Pálóczi, N Faragó, Á Zvara, ... Journal of molecular and cellular cardiology 62, 111-121, 2013	200	2013
PARP inhibition protects against alcoholic and non-alcoholic steatohepatitis P Mukhopadhyay, B Horváth, M Rajesh, ZV Varga, K Gariani, D Ryu, ... Journal of hepatology 66 (3), 589-600, 2017	164	2017
Alcohol misuse and kidney injury: epidemiological evidence and potential mechanisms ZV Varga, C Matyas, J Paloczi, P Pacher Alcohol research: current reviews 38 (2), 283, 2017	128	2017
Neuroprotection in oxidative stress-related neurodegenerative diseases: role of endocannabinoid system modulation J Paloczi, ZV Varga, G Hasko, P Pacher Antioxidants & redox signaling 29 (1), 75-108, 2018	116	2018
Macrophage P2X4 receptors augment bacterial killing and protect against sepsis B Csóka, ZH Németh, I Szabó, DL Davies, ZV Varga, J Pálóczi, S Falzoni, ... JCI insight 3 (11), 2018	111	2018
β‐Caryophyllene protects against alcoholic steatohepatitis by attenuating inflammation and metabolic dysregulation in mice ZV Varga, C Matyas, K Erdelyi, R Cinar, D Nieri, A Chicca, BT Nemeth, ... British journal of pharmacology 175 (2), 320-334, 2018	98	2018
Pepcan-12 (RVD-hemopressin) is a CB2 receptor positive allosteric modulator constitutively secreted by adrenals and in liver upon tissue damage V Petrucci, A Chicca, S Glasmacher, J Paloczi, Z Cao, P Pacher, J Gertsch Scientific reports 7 (1), 9560, 2017	85	2017
Chronic plus binge ethanol feeding induces myocardial oxidative stress, mitochondrial and cardiovascular dysfunction, and steatosis C Matyas, ZV Varga, P Mukhopadhyay, J Paloczi, T Lajtos, K Erdelyi, ... American Journal of Physiology-Heart and Circulatory Physiology 310 (11 …, 2016	84	2016
Discovery of a NAPE-PLD inhibitor that modulates emotional behavior in mice ED Mock, M Mustafa, O Gunduz-Cinar, R Cinar, GN Petrie, V Kantae, X Di, ... Nature chemical biology 16 (6), 667-675, 2020	78	2020
Bile acid–activated macrophages promote biliary epithelial cell proliferation through integrin αvβ6 upregulation following liver injury A Guillot, L Guerri, D Feng, SJ Kim, YA Ahmed, J Paloczi, Y He, ... The Journal of clinical investigation 131 (9), 2021	67	2021
Interplay of liver–heart inflammatory axis and cannabinoid 2 receptor signaling in an experimental model of hepatic cardiomyopathy C Matyas, K Erdelyi, E Trojnar, S Zhao, ZV Varga, J Paloczi, ... Hepatology 71 (4), 1391-1407, 2020	67	2020
PCSK9 inhibition as a novel therapeutic target for alcoholic liver disease JS Lee, P Mukhopadhyay, C Matyas, E Trojnar, J Paloczi, YR Yang, ... Scientific reports 9 (1), 17167, 2019	67	2019
Cannabinoid‐1 receptor deletion in podocytes mitigates both glomerular and tubular dysfunction in a mouse model of diabetic nephropathy T Jourdan, JK Park, ZV Varga, J Pálóczi, NJ Coffey, AZ Rosenberg, ... Diabetes, Obesity and Metabolism 20 (3), 698-708, 2018	60	2018
Preconditioning protects the heart in a prolonged uremic condition GF Kocsis, M Sárközy, P Bencsik, M Pipicz, ZV Varga, J Pálóczi, ... American Journal of Physiology-Heart and Circulatory Physiology 303 (10 …, 2012	55	2012
Disruption of renal arginine metabolism promotes kidney injury in hepatorenal syndrome in mice ZV Varga, K Erdelyi, J Paloczi, R Cinar, ZK Zsengeller, T Jourdan, ... Hepatology 68 (4), 1519-1533, 2018	54	2018
Activation of PPARβ/δ protects cardiac myocytes from oxidative stress-induced apoptosis by suppressing generation of reactive oxygen/nitrogen species and expression of matrix … E Barlaka, A Görbe, R Gáspár, J Pálóczi, P Ferdinandy, A Lazou Pharmacological research 95, 102-110, 2015	51	2015
Structural basis of selective cannabinoid CB₂ receptor activation X Li, H Chang, J Bouma, LV de Paus, P Mukhopadhyay, J Paloczi, ... Nature Communications 14 (1), 1447, 2023	48	2023
Moderate inhibition of myocardial matrix metalloproteinase-2 by ilomastat is cardioprotective P Bencsik, J Pálóczi, GF Kocsis, J Pipis, I Belecz, ZV Varga, C Csonka, ... Pharmacological Research 80, 36-42, 2014	41	2014
Cholesterol-enriched diet inhibits cardioprotection by ATP-sensitive K⁺ channel activators cromakalim and diazoxide C Csonka, K Kupai, P Bencsik, A Görbe, J Pálóczi, Á Zvara, LG Puskás, ... American Journal of Physiology-Heart and Circulatory Physiology 306 (3 …, 2014	40	2014
Cardioprotection by farnesol: role of the mevalonate pathway G Szűcs, Z Murlasits, S Török, GF Kocsis, J Pálóczi, A Görbe, T Csont, ... Cardiovascular drugs and therapy 27, 269-277, 2013	35	2013

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Seguir

Citado por

Coautores